Literature DB >> 26474702

Activation of farnesoid X receptor downregulates monocyte chemoattractant protein-1 in murine macrophage.

Liangpeng Li1, Qian Zhang1, Jiahe Peng1, Chanjui Jiang1, Yan Zhang1, Lili Shen1, Jinyu Dong1, Yongchao Wang1, Yu Jiang2.   

Abstract

Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily, which plays important roles in bile acids/lipid homeostasis and inflammation. Monocyte chemoattractant protein-1 (MCP-1) contributes to macrophage infiltration into body tissues during inflammation. Here we investigated whether FXR can regulate MCP-1 expression in murine macrophage. FXR activation down regulate MCP-1 mRNA and protein levels in ANA-1 and Raw264.7 cells. Luciferase reporter assay, Gel shift and Chromatin immunoprecipitation assays have revealed that the activated FXR bind to the FXR element located in -738 bp ∼  -723 bp in MCP-1 promoter. These results suggested that FXR may serve as a novel target for regulating MCP-1 levels for the inflammation related diseases therapies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bile acids; Farnesoid X receptor; Inflammation; Macrophage; Monocyte chemoattractant protein-1

Mesh:

Substances:

Year:  2015        PMID: 26474702     DOI: 10.1016/j.bbrc.2015.10.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.

Authors:  Justin D Schumacher; Bo Kong; Jason Wu; Daniel Rizzolo; Laura E Armstrong; Monica D Chow; Michael Goedken; Yi-Horng Lee; Grace L Guo
Journal:  Hepatology       Date:  2019-08-09       Impact factor: 17.425

Review 2.  Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis.

Authors:  Justin D Schumacher; Grace L Guo
Journal:  Handb Exp Pharmacol       Date:  2019

Review 3.  Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis.

Authors:  Tongyao Wang; Xingyu Rong; Chao Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

4.  Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.

Authors:  Laura E Armstrong; Grace L Guo
Journal:  Curr Pharmacol Rep       Date:  2017-02-21

Review 5.  Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.

Authors:  Ronan Thibaut; Matthew C Gage; Inès Pineda-Torra; Gwladys Chabrier; Nicolas Venteclef; Fawaz Alzaid
Journal:  FEBS J       Date:  2021-05-02       Impact factor: 5.622

Review 6.  Enhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy Connection.

Authors:  Gustav van Niekerk; Suzèl M Hattingh; Anna-Mart Engelbrecht
Journal:  Front Oncol       Date:  2016-11-14       Impact factor: 6.244

7.  Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH.

Authors:  Jonathan D Roth; Sanne S Veidal; Louise K D Fensholdt; Kristoffer T G Rigbolt; Romeo Papazyan; Jens Christian Nielsen; Michael Feigh; Niels Vrang; Mark Young; Jacob Jelsing; Luciano Adorini; Henrik H Hansen
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

8.  Bile Acid Regulates Mononuclear Phagocytes and T Helper 17 Cells to Control Candida albicans in the Intestine.

Authors:  Abhishek Datta; Juan F Hernandez-Franco; Sungtae Park; Matthew R Olson; Harm HogenEsch; Shankar Thangamani
Journal:  J Fungi (Basel)       Date:  2022-06-07

9.  Bile Acid Regulates the Colonization and Dissemination of Candida albicans from the Gastrointestinal Tract by Controlling Host Defense System and Microbiota.

Authors:  Shankar Thangamani; Ross Monasky; Jung Keun Lee; Vijay Antharam; Harm HogenEsch; Tony R Hazbun; Yan Jin; Haiwei Gu; Grace L Guo
Journal:  J Fungi (Basel)       Date:  2021-11-30

Review 10.  Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease.

Authors:  Yang Xiao; Mindy Kim; Mitchell A Lazar
Journal:  Mol Metab       Date:  2020-11-18       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.